McCollum Christoferson Group LLC Has $2.19 Million Holdings in Colgate-Palmolive (NYSE:CL)

McCollum Christoferson Group LLC trimmed its holdings in Colgate-Palmolive (NYSE:CL) by 2.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 21,098 shares of the company’s stock after selling 528 shares during the period. McCollum Christoferson Group LLC’s holdings in Colgate-Palmolive were worth $2,190,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently modified their holdings of CL. E Fund Management Hong Kong Co. Ltd. bought a new stake in Colgate-Palmolive during the 2nd quarter worth approximately $25,000. Rise Advisors LLC acquired a new stake in shares of Colgate-Palmolive during the first quarter worth $38,000. Continuum Advisory LLC raised its holdings in shares of Colgate-Palmolive by 46.5% during the second quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock worth $38,000 after acquiring an additional 125 shares during the period. Register Financial Advisors LLC bought a new stake in Colgate-Palmolive in the 1st quarter valued at $48,000. Finally, Gradient Investments LLC increased its holdings in Colgate-Palmolive by 150.4% during the 2nd quarter. Gradient Investments LLC now owns 666 shares of the company’s stock worth $65,000 after purchasing an additional 400 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors.

Insider Activity at Colgate-Palmolive

In other news, insider Sally Massey sold 15,850 shares of Colgate-Palmolive stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the completion of the sale, the insider now owns 13,942 shares of the company’s stock, valued at approximately $1,439,929.76. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, insider Sally Massey sold 15,850 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total value of $1,636,988.00. Following the completion of the sale, the insider now directly owns 13,942 shares in the company, valued at approximately $1,439,929.76. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Gregory Malcolm sold 10,533 shares of the stock in a transaction that occurred on Tuesday, August 6th. The stock was sold at an average price of $103.10, for a total value of $1,085,952.30. Following the sale, the executive vice president now directly owns 10,377 shares in the company, valued at $1,069,868.70. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 43,490 shares of company stock worth $4,486,063 in the last ninety days. 0.34% of the stock is owned by company insiders.

Colgate-Palmolive Trading Down 0.3 %

CL stock opened at $101.20 on Thursday. Colgate-Palmolive has a one year low of $71.22 and a one year high of $109.30. The stock has a market cap of $83.03 billion, a price-to-earnings ratio of 32.03, a price-to-earnings-growth ratio of 3.54 and a beta of 0.40. The company has a fifty day moving average price of $103.51 and a two-hundred day moving average price of $97.44. The company has a debt-to-equity ratio of 16.90, a current ratio of 1.06 and a quick ratio of 0.70.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, July 26th. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.87 by $0.04. The business had revenue of $5.06 billion during the quarter, compared to the consensus estimate of $5 billion. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. Colgate-Palmolive’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.77 EPS. Equities analysts anticipate that Colgate-Palmolive will post 3.57 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be issued a dividend of $0.50 per share. The ex-dividend date is Friday, October 18th. This represents a $2.00 annualized dividend and a yield of 1.98%. Colgate-Palmolive’s payout ratio is currently 63.29%.

Analysts Set New Price Targets

CL has been the topic of a number of research reports. Morgan Stanley boosted their price target on Colgate-Palmolive from $103.00 to $111.00 and gave the company an “overweight” rating in a report on Monday, July 29th. BNP Paribas began coverage on Colgate-Palmolive in a research report on Monday, June 24th. They set an “outperform” rating and a $109.00 price target for the company. Wells Fargo & Company downgraded shares of Colgate-Palmolive from an “equal weight” rating to an “underweight” rating and set a $100.00 price objective on the stock. in a report on Monday, September 16th. Barclays increased their target price on shares of Colgate-Palmolive from $91.00 to $96.00 and gave the stock an “equal weight” rating in a report on Monday, July 29th. Finally, Bank of America lifted their price target on shares of Colgate-Palmolive from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Wednesday, July 10th. One analyst has rated the stock with a sell rating, eight have given a hold rating and fourteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $106.00.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.